Shell Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-17,595	Closed	-$24K	–	1279
2023 Q1	$24K	Sell	17,595 -58	-0.3%	-$115	﹤0.01%	1226
2022 Q4	$35K	Sell	17,653 -37,869	-68%	-$84.9K	﹤0.01%	1296
2022 Q3	$112K	Sell	55,522 -7,324	-12%	-$20.5K	﹤0.01%	1187
2022 Q2	$200K	Buy	62,846 +107	+0.2%	+$388	0.01%	1123
2022 Q1	$262K	Sell	62,739 -9,283	-13%	-$41.1K	0.01%	1089
2021 Q4	$345K	Buy	72,022 +331	+0.5%	+$1.65K	0.01%	1059
2021 Q3	$383K	Sell	71,691 -3,080	-4%	-$15.5K	0.01%	980
2021 Q2	$383K	Buy	74,771 +4,050	+6%	+$23K	0.01%	1026
2021 Q1	$476K	Buy	70,721 +25,642	+57%	+$142K	0.01%	875
2020 Q4	$206K	Buy	+45,079	New	+$200K	﹤0.01%	1104
2019 Q2	–	Sell	-12,657	Closed	-$179K	–	1226
2019 Q1	$179K	Hold	12,657	–	–	﹤0.01%	1119
2018 Q4	$171K	Sell	12,657 -1,100	-8%	-$19.8K	﹤0.01%	1056
2018 Q3	$305K	Buy	+13,757	New	+$290K	0.01%	1065